180 related articles for article (PubMed ID: 26902929)
1. Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma.
Ritter C; Fan K; Paulson KG; Nghiem P; Schrama D; Becker JC
Sci Rep; 2016 Feb; 6():21678. PubMed ID: 26902929
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma.
Ritter C; Fan K; Paschen A; Reker Hardrup S; Ferrone S; Nghiem P; Ugurel S; Schrama D; Becker JC
Sci Rep; 2017 May; 7(1):2290. PubMed ID: 28536458
[TBL] [Abstract][Full Text] [Related]
3. The HDAC Inhibitor Domatinostat Promotes Cell-Cycle Arrest, Induces Apoptosis, and Increases Immunogenicity of Merkel Cell Carcinoma Cells.
Song L; Bretz AC; Gravemeyer J; Spassova I; Muminova S; Gambichler T; Sriram A; Ferrone S; Becker JC
J Invest Dermatol; 2021 Apr; 141(4):903-912.e4. PubMed ID: 33002502
[TBL] [Abstract][Full Text] [Related]
4. MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case series.
Ugurel S; Spassova I; Wohlfarth J; Drusio C; Cherouny A; Melior A; Sucker A; Zimmer L; Ritter C; Schadendorf D; Becker JC
Cancer Immunol Immunother; 2019 Jun; 68(6):983-990. PubMed ID: 30993371
[TBL] [Abstract][Full Text] [Related]
5. The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells.
Zhu S; Denman CJ; Cobanoglu ZS; Kiany S; Lau CC; Gottschalk SM; Hughes DP; Kleinerman ES; Lee DA
Pharm Res; 2015 Mar; 32(3):779-92. PubMed ID: 24203492
[TBL] [Abstract][Full Text] [Related]
6. The histone deacetylase inhibitor trichostatin a promotes apoptosis and antitumor immunity in glioblastoma cells.
Höring E; Podlech O; Silkenstedt B; Rota IA; Adamopoulou E; Naumann U
Anticancer Res; 2013 Apr; 33(4):1351-60. PubMed ID: 23564772
[TBL] [Abstract][Full Text] [Related]
7. Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells.
Zingoni A; Cecere F; Vulpis E; Fionda C; Molfetta R; Soriani A; Petrucci MT; Ricciardi MR; Fuerst D; Amendola MG; Mytilineos J; Cerboni C; Paolini R; Cippitelli M; Santoni A
J Immunol; 2015 Jul; 195(2):736-48. PubMed ID: 26071561
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the HDAC/Suv39/G9a pathway restores the expression of DNA damage-dependent major histocompatibility complex class I-related chain A and B in cancer cells.
Nakajima NI; Niimi A; Isono M; Oike T; Sato H; Nakano T; Shibata A
Oncol Rep; 2017 Aug; 38(2):693-702. PubMed ID: 28677817
[TBL] [Abstract][Full Text] [Related]
9. Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma.
Sengupta D; Kannan A; Kern M; Moreno MA; Vural E; Stack B; Suen JY; Tackett AJ; Gao L
Epigenetics; 2015; 10(6):460-6. PubMed ID: 25941994
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.
Armeanu S; Bitzer M; Lauer UM; Venturelli S; Pathil A; Krusch M; Kaiser S; Jobst J; Smirnow I; Wagner A; Steinle A; Salih HR
Cancer Res; 2005 Jul; 65(14):6321-9. PubMed ID: 16024634
[TBL] [Abstract][Full Text] [Related]
11. Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma.
Belting L; Hömberg N; Przewoznik M; Brenner C; Riedel T; Flatley A; Polić B; Busch DH; Röcken M; Mocikat R
Eur J Immunol; 2015 Sep; 45(9):2593-601. PubMed ID: 26151313
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells.
Kato N; Tanaka J; Sugita J; Toubai T; Miura Y; Ibata M; Syono Y; Ota S; Kondo T; Asaka M; Imamura M
Leukemia; 2007 Oct; 21(10):2103-8. PubMed ID: 17625602
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma.
Paulson KG; Tegeder A; Willmes C; Iyer JG; Afanasiev OK; Schrama D; Koba S; Thibodeau R; Nagase K; Simonson WT; Seo A; Koelle DM; Madeleine M; Bhatia S; Nakajima H; Sano S; Hardwick JS; Disis ML; Cleary MA; Becker JC; Nghiem P
Cancer Immunol Res; 2014 Nov; 2(11):1071-9. PubMed ID: 25116754
[TBL] [Abstract][Full Text] [Related]
14. IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA.
Kloess S; Huenecke S; Piechulek D; Esser R; Koch J; Brehm C; Soerensen J; Gardlowski T; Brinkmann A; Bader P; Passweg J; Klingebiel T; Schwabe D; Koehl U
Eur J Immunol; 2010 Nov; 40(11):3255-67. PubMed ID: 21061445
[TBL] [Abstract][Full Text] [Related]
15. Combination of retinoid and histone deacetylase inhibitor produced an anti-tumor effect in cutaneous T-cell lymphoma by restoring tumor suppressor gene, retinoic acid receptorβ2, via histone acetylation.
Kato Y; Egusa C; Maeda T; Tsuboi R
J Dermatol Sci; 2016 Jan; 81(1):17-25. PubMed ID: 26596218
[TBL] [Abstract][Full Text] [Related]
16. Merkel cell carcinoma and cellular cytotoxicity: sensitivity to cellular lysis and screening for potential target antigens suitable for antibody-dependent cellular cytotoxicity.
Ollier J; Kervarrec T; Samimi M; Benlalam H; Aumont P; Vivien R; Touzé A; Labarrière N; Vié H; Clémenceau B
Cancer Immunol Immunother; 2018 Aug; 67(8):1209-1219. PubMed ID: 29808366
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia increases tumor cell shedding of MHC class I chain-related molecule: role of nitric oxide.
Siemens DR; Hu N; Sheikhi AK; Chung E; Frederiksen LJ; Pross H; Graham CH
Cancer Res; 2008 Jun; 68(12):4746-53. PubMed ID: 18559521
[TBL] [Abstract][Full Text] [Related]
18. Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity.
Ning ZQ; Li ZB; Newman MJ; Shan S; Wang XH; Pan DS; Zhang J; Dong M; Du X; Lu XP
Cancer Chemother Pharmacol; 2012 Apr; 69(4):901-9. PubMed ID: 22080169
[TBL] [Abstract][Full Text] [Related]
19. Enhancer of Zeste Homolog 2 Inhibition Induces HLA Class I Re-Expression in Merkel Cell Carcinoma.
Durand MA; Drouin A; Bachiri K; Durand L; Berthon P; Houben R; Schrama D; Coyaud E; Samimi M; Touzé A; Kervarrec T
J Invest Dermatol; 2024 Jun; 144(6):1398-1401.e1. PubMed ID: 38052265
[No Abstract] [Full Text] [Related]
20. The HDAC inhibitor domatinostat induces type I interferon α in Merkel cell carcinoma by HES1 repression.
Srinivas N; Song L; Lei KC; Gravemeyer J; Furtmann F; Gambichler T; Becker JC; Sriram A
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8267-8277. PubMed ID: 37071208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
